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Many pathogenic bacteria have sophisticated mech-
anisms to interfere with the mammalian immune
response. These include the disruption of host extra-
cellular ATP levels that, in humans, is tightly regulated
by the nucleoside triphosphate diphosphohydrolase
family (NTPDases). NTPDases are found almost
exclusively in eukaryotes, the notable exception
being their presence in some pathogenic prokary-
otes. To address the function of bacterial NTPDases,
we describe the structures of an NTPDase from
the pathogen Legionella pneumophila (Lpg1905/
Lp1NTPDase) in its apo state and in complex with
the ATP analog AMPPNP and the subtype-specific
NTPDase inhibitor ARL 67156. Lp1NTPDase is
structurally and catalytically related to eukaryotic
NTPDases and the structure provides a basis for
NTPDase-specific inhibition. Furthermore, we dem-
onstrate that the activity of Lp1NTPDase correlates
directly with intracellular replication of Legionella
within macrophages. Collectively, these findings
provide insight into the mechanism of this enzyme
and highlight its role in host-pathogen interactions.
INTRODUCTION
All cell types have the potential to release extracellular nucleo-
tides (NTP), and in particular ATP, into the extracellular space
where it can affect a wide range of mammalian physiological func-
tions, including blood clotting, inflammation, immune reactions,
smooth muscle contraction, and cell proliferation (Bours et al.,
2006; Robson et al., 2006; Zimmermann, 2006). ATP can be either
constitutively secreted or released when cells are stimulated in
response to physiological or pathophysiological changes (Lazar-
owski et al., 2003). Extracellular ATP signals via specific puriner-
gic receptors, termed type 1 (P1) and type 2 (P2X and P2Y). The
P1 receptors are activated by adenosine that is generated by
the action of ecto-nucleotidases (Burnstock, 2007). The P2X228 Structure 18, 228–238, February 10, 2010 ª2010 Elsevier Ltd Allreceptors are ligand-gated ion channels that are specific to ATP,
and the P2Y receptors are G protein-coupled receptors that are
activated by ATP, ADP, UTP, UDP, ITP and nucleotide sugars.
The levels of extracellular nucleotides must be tightly regulated
to prevent aberrant purinergic signaling events.
A family of enzymes termed the ecto-nucleoside triphosphate
diphosphohydrolases (NTPDases) control the extracellular levels
of NTPs (Zimmermann, 2000). In mammals, there are eight
members of the NTPDase family (1 to 8) that are collectively
characterized by the presence of five apyrase-conserved
regions (ACR1 to 5), which range from 4 to 13 residues in length
(Sansom et al., 2008b; Zimmermann, 2000). ACRs form the
active site of NTPDases, in which ACRs 1 and 4 correspond to
the b and g-phosphate binding domains of the actin/Hsp70/
hexokinase superfamily (Hurley, 1996; Smith and Kirley, 1998).
The NTPDase family members exhibit different cellular locations,
nucleotide preference, hydrolysis rates of NTPs and NDPs, and
all are activated by divalent metal ions (Knowles and Li, 2006;
Robson et al., 2006; Zimmermann, 2000). For example,
NTPDases1, 2, 3, and 8 are located in the plasma membrane,
whereas NTPDase4 is located in the Golgi (Zimmermann,
2000). NTPDases1-4 and 7-8 are anchored to the membrane
via N- and C-terminal transmembrane domains that interact
with each other and act as the site for tetramerisation, which in
turn regulates the enzyme activity of these NTPDases (Robson
et al., 2006). In contrast, NTPDases5 and 6 are produced as
soluble proteins (Braun et al., 2000; Chadwick and Frischauf,
1998; Mulero et al., 1999). NTPDases1, 2, and 3 hydrolyze
a range of nucleotides at different ratios, while NTPDase4 shows
a preference for UTP and UDP (Wang and Guidotti, 1998).
NTPDase1 can hydrolysze both ATP and ADP with an ATP:ADP
ratio of 1:1; in addition, NTPDase1 can also hydrolyze ATP to
AMP processively. NTPDase2 has strong activity for ATP, with
an ATP:ADP ratio of 1:0.03, while NTPDase3 is intermediate
with an ATP:ADP ratio 1:0.3 (Heine et al., 1999; Kaczmarek
et al., 1996; Wang et al., 1998). Recently, the structural basis
of enzyme catalysis by the NTPDase2 from Rattus norvegicus
was proposed (Zebisch and Stra¨ter, 2008). The structure of
RnNTPDase2 revealed how the ACR regions bind to ATP and
suggested a mechanism for ATP hydrolysis via a catalytic gluta-
mate. Nevertheless, the structural basis of several aspects ofrights reserved
Table 1. Data Collection and Refinement Statistics
Data set
Apo
Lp1NTPDase
Lp1NTPDase-
ARL 67156
Lp1NTPDase-
AMPPNP
Wavelength (A˚) 0.979 0.954 0.954
Space group P321 P321 P321
Cell dimensions
(A˚) (a,b,c)
103.8,
103.8, 75.4
101.5,
101.5, 74.9
104.7,
104.7, 75.4
Resolution (A˚) 40 - 1.6
(1.69 - 1.60)
40 - 2.0
(2.11 - 2.00)
35-1.65
(1.74-1.65)
Total number
of observations
1321984 126891 418681
Number of unique
observations
62027 30076 55849
Multiplicity 21.3 (20.7) 4.2 (4.2) 7.5 (7.3)
Data
completeness (%)
99.9 (100) 99.9 (100) 97.6 (98.8)
I/sI 33.5 (4.4) 21.2 (2.6) 14.3 (3.5)
Rpim
a 2.1 (13.7) - -
Rmerge
b 8.5 (47.5) 8.9 (38.2) 11.9 (45.2)
Non-hydrogen atoms
Protein 2790 2765 2947
Water 423 226 492
Rfactor
c 18.8 18.4 17.6
Rfree
c 20.7 22.4 19.7
Rmsd from ideal values
Bond lengths (A˚) 0.014 0.014 0.011
Bond angles
(degrees)
1.494 1.494 1.230
Ramachandran plot (%)
Most favored region 96.6 96.0 92.3
Additional allowed
regions
3.4 4.0 7.7
B-factors (A˚2)
Average main chain 17.0 30.1 14.0
Average side chain 24.0 34.4 16.0
Average water
molecule
35.0 45.4 32.0
Average ligand/ion - 47.4 23.9
a Rpim = O(1/(n - 1)) $
P
(jIi – Imeanj)/
P
(Ii).
b Rmerge =
P
hkl
P
j jIhkl,j - < Ihkl > j /
P
hkl
P
j Ihkl,j.
c Rfactor =
P
hklkFoj - jFck/
P
hkljFoj for all data excluding the 5% that
comprised the Rfree used for cross-validation.
Structure
Structure of Legionella NTPDaseNTPDase activity remains unclear, such as the nucleotide base
discrimination, diphosphate/triphosphate discrimination, and
differing metal ion activation.
The differential rates of ADP hydrolysis are crucial to the regu-
lation of purinergic signaling. NTPDase1, also referred to as the
lymphoid cell activation antigen CD39, hydrolyzes ATP to AMP
without the release of ADP (Kaczmarek et al., 1996). As ADP
acts as a platelet activator, the hydrolysis of ATP to AMP aids
in blood flow and blocks platelet activation. Mice deficient in
NTPDase1 have disordered thromboregulation, which can be
reversed upon the addition of soluble NTPDase1, thereby
making NTPDase1 an attractive therapeutic for the treatment
of stroke patients (Enjyoji et al., 1999; Jackson et al., 2007).
However, the enzyme activity of soluble NTPDase1 as compared
to membrane-bound NTPDase1 is severely reduced, limiting the
effectiveness of NTPDase1 as a drug (Gayle et al., 1998). Several
attempts have been made to synthesize inhibitors of NTPDase to
regulate their activity (Crack et al., 1995; Gendron et al., 2002;
Mu¨ller et al., 2006). For example, 6-N,N-diethyl-D-b-g-dibromo-
methylene adenosine triphosphate (ARL 67156), a non-hydrolys-
able analog of ATP (Crack et al., 1995), is a subtype-specific
NTPDase inhibitor that can inhibit NTPDase1 and 3; however,
it has no effect against NTPDase2 and NTPDase8 (Le´vesque
et al., 2007).
Many pathogens can interfere with essential cellular events
and some pathogens can manipulate the ATP levels of the
host. For example, the intracellular bacterial pathogens Shigella,
Mycobacteria, and Porphyromonas, as well as the Leishmania
parasite, secrete ATP-utilizing enzymes (unrelated to NTPDases)
that have the potential to manipulate levels of ATP and therefore
interfere with purinergic signaling (Buchrieser et al., 2000; Kolli
et al., 2008; Yilmaz et al., 2008; Zaborina et al., 1999). In addition,
all protozoan parasites possess NTPDase homologs of the
NTPDase1 family (Roberto Meyer-Fernandes, 2002); however,
their role in the biology of the organism and their contribution
to the pathogenesis of disease is poorly understood. Recently,
an NTPDase homolog (Lpg1905) was characterized from the
intracellular bacterial pathogen Legionella pneumophila, the
causative agent of Legionnaire’s disease (Sansom et al., 2007,
2008a). As Lpg1905 has been shown to possess NTPDase
activity and is inhibited by ARL 67156, we refer to Lpg1905
from herein as Lp1NTPDase, as it is the first NTPDase described
from Legionella. Since NTPDases are found almost exclusively in
eukaryotic organisms, the presence of an NTPDase mimic in the
bacterium L. pneumophila raised the possibility that these micro-
bial enzymes may contribute to host-pathogen interactions.
Previous work showed that Lp1NTPDase enhanced bacterial
replication in macrophages and amoebae and was required for
virulence in a mouse lung infection model (Sansom et al., 2007,
2008a). Unlike most of the mammalian NTPDases however,
Lp1NTPDase was soluble and did not require membrane associ-
ation to regulate its catalytic activity.
To further our understanding of the microbial NTPDase family,
we have determined the crystal structure of Lp1NTPDase in its
apo-state and in complex with an ATP analog and ARL 67156.
These structures, together with functional data, show that the
bacterial enzyme, Lp1NTPDase, is a structural and functional
mimic of mammalian NTPDases that contributes to host-path-
ogen interactions through its NTPDase activity.Structure 18, 228RESULTS
Crystal Structure of apo Lp1NTPDase
To gain detailed insight into the structure and function of the
microbial NTPDase family, we determined the 1.6 A˚ resolution
structure of the apo-form of Lp1NTPDase (residues 41-393 of
the native protein were visible in the electron density) and refined
it to Rfactor and Rfree values of 18.8% and 20.7%, respectively
(Table 1). Lp1NTPDase crystallized as a monomer in the
asymmetric unit and there was no evidence for higher-order
oligomeric assemblies in the crystal lattice, which was con-
sistent with Lp1NTPDase being purified as a monomer via–238, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 229
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Figure 1. Crystal Structure of the apo
Lp1NTPDase
(A) Overall architecture of the X-ray structure of
Lp1NTPDase. Domain 1 and domain 2 are colored
in orange and gray, respectively. The two-disulfide
bonds are colored in magenta.
(B) The ACR regions are highlighted on the
Lp1NTPDase structure with AMPPNP shown in
stick form. The ACR1, ACR2, ACR3, ACR4, and
ACR5 are colored in cyan, pink, green, blue, and
light blue, respectively.
Structure
Structure of Legionella NTPDasesize-exclusion chromatography. The Lp1NTPDase protomer
adopted a bi-lobal structure with dimensions ofz55 A˚3 45 A˚3
45 A˚, comprising 23% b sheet and 37% a helix (Figure 1A).
Domain 1 (residues 41-153 and 379-389) resembles an RNase
H fold and consists of a mixed five-stranded b sheet that is
flanked by four a helices on one side and the C-terminal helix
on the other. Domain 2 (residues 154-378) also consists of a
mixed five-stranded b sheet flanked by two and eight a helices
on either side of the b sheet. A b-hairpin motif (11,12) is linked
to helix F via a disulfide bond, C244-C264. An additional disulfide
bond (C330-C351) links helix I to helix K (Figure 1A). The ACR 1230 Structure 18, 228–238, February 10, 2010 ª2010 Elsevier Ltd All rights reservedand 4 regions, which share homology to
b and g-phosphate binding domains of
actin/Hsp70/hexokinase superfamily, are
located in the b1 and b8 strands, respec-
tively, while ACRs 2, 3, and 5 are located
on helix B, D, and L, respectively (Fig-
ure 1B). Accordingly, all the ACR regions
are clustered around the interdomain
junction and collectively define the candi-
date active site of Lp1NTPDase.
A structure-based search of the Protein
Data Bank using DALI (Holm et al., 2008)
identified NTPDase2 from Rattus norvegi-
cus (PDB code: 3cj1) as the closest struc-
tural homolog to Lp1NTPDase (Z-score
of 32, 26% sequence identity, rmsd of
2.7 A˚ over 327 Ca atoms), with the
majority of conservation residing within
the ACR regions (Figure 2A). Accordingly,
despite the low sequence identity
betweenRnNTPDase2 and Lp1NTPDase,
their overall folds are largely conserved
(Figure 2B). There is approximately
a 7 difference in the interdomain angle
between Lp1NTPDase and RnNTPDase2
(see Experimental Procedures). The long
extension observed in the RnNTDPase2
structure (shown in red in Figure 2B),
which is considered to interact/insert
within the cell membrane (Zebisch and
Stra¨ter, 2008), is not present in the soluble
Lp1NTPDase structure and is replaced by
a much shorter loop connecting helix E to
b strand 14. In addition, the positions of
the disulfide bonds in Lp1NTPDase areconserved with two of the five disulfide bonds observed in the
RnNTPDase2 structure. These disulfide bonds are similarly
conserved in NTPDase6, as shown by disulfide mapping and
mass spectrometry (Ivanenkov et al., 2003). The presence of
these disulfides appears to be required for the correct folding
of NTPDases, as the mutation of Cys399 in NTPDase2 results
in a misfolded protein that is not released from the endoplasmic
reticulum (Mateo et al., 2003). The next closest structural homo-
logs to Lp1NTPDase are the exopolyphosphatases and kinases
(Z-score between 10 and 22) that have been identified as
members of the acetate and sugar kinases/Hsc70/actin (ASKHA)
Figure 2. Comparison of Lp1NTPDase Structure with RnNTPDase2 Structure
(A) Structure-based sequence alignment with identical residues shaded in black and conserved residues shaded in gray.
(B) Superposition of the apo Lp1NTPDase X-ray structure (pale green) and theRattus Norvegicus RnNTPase2 (PDB code: 3cj1) (orange) (see Experimental Proce-
dures). The loop shown red is proposed to interact with the membrane.
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Structure of Legionella NTPDase
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Figure 3. Close-up View of the ATP Binding Site of Lp1NTPDase
Electron density maps shown are Fo - Fc simulated annealing omit maps con-
toured at 3s. AMPPNP-mediated hydrogen bonds with Lp1NTPDase are
shown as black dashed lines. The water-mediated hydrogen bonds are shown
as magenta dashed lines with water molecules shown in orange.
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Structure of Legionella NTPDasesuperfamily [ribonuclease H-like, group 4] (Hurley, 1996). The
structural homology between Lp1NTPDase and RnNTPDase2,
coupled with the sequence conservation of ACRs in all members
of NTPDase family (Figure 2B), suggests that the NTPDases all
possess the same scaffold, while subtle differences in sequence
and structure mold the enzyme activity.
Crystal Structure of Lp1NTPDase with the ATP Analog
AMPPNP
To identify the active site and gain insight into the catalytic mech-
anism of Lp1NTPDase, we determined the 1.65 A˚ resolution
structure of Lp1NTPDase in complex with the ATP analog
AMPPNP to Rfactor and Rfree values of 17.6% and 19.7%, respec-
tively (Table 1). The overall architecture of the Lp1NTPDase-
AMPPNP structure was very similar to the apo-form (rmsd of
0.5 A˚ for 349 Ca atoms), with small side-chain movements being
observed to accommodate the AMPPNP (not shown). AMPPNP
was bound in an extended conformation spanning the crevice
between the K and H helices where the adenine base was
packed, to the center of the molecule where the g-phosphate
was surrounded by the ACR regions (Figure 1B).
The adenine ring resides in a hydrophobic pocket formed by
G299, N302, L303, Y346, Y350, and L353. The adenine base
lies stacked between the aromatic ring of Y346 and the
aliphatic chain of N302. Hydrogen bonds are also formed to
the amine group of the adenine base by the hydroxyl group
of Y350 and a water-mediated hydrogen bond with the carbox-
ylate of D344. The predominantly nonspecific, hydrophobic
interaction between the adenine base and the binding pocket
is reflected in the low base specificity of the enzyme that is
able to utilize both ATP and GTP. The enzyme is also able to
hydrolyze CTP and UTP, though with a greatly reduced efficacy
(Sansom et al., 2008a) (Figure 3A; see Table S1 available
online).
A predominate conformation of AMPPNP was observed in
complex with Lp1NTPDase by a series of crystal soaking exper-
iments in the presence of calcium (see below; data not shown).
Interestingly, there was electron-density indicative of other
conformations of the phosphate groups of AMPPNP in the
active site; however, attempts to accurately model these were
unsuccessful. Though the predominant AMPPNP conformation
was clearly resolved in the electron density, the potential
for other conformations suggests there is flexibility of these
moieties within the active site. Consistent with this, the majority
of contacts to these groups are water mediated within the
Lp1NTPDase-AMPPNP structure (Figure 3). The ribose group
adopts a C20 endo conformation, with its O2-hydroxyl moiety
hydrogen bonded to the hydroxyl group of Y346. The majority
of interactions with the phosphate moieties of AMPPNP are
mediated by residues in ACR 1 (S52, T53, R56) and ACR 4
(G189), the regions that have highest homology to b and g-phos-
phate binding domains of actin/Hsp70/hexokinase superfamily
(Hurley, 1996). The a-, b-, and g- phosphates form an intricate
series of water-mediated hydrogen bonds and a few direct
hydrogen bonds with Lp1NTPDase. The a-phosphate forms
one water-mediated hydrogen bond with D186 (Figure 3); the
b-phosphate is coordinated to K80, G189, and R56 by water-
mediated hydrogen bonds, while the amide backbone of T53
forms a direct hydrogen bond with the oxygen of the g-phos-232 Structure 18, 228–238, February 10, 2010 ª2010 Elsevier Ltd Allphate. Accordingly, the phosphate moieties of AMPPNP exhibit
flexibility within the active site of Lp1NTPDase.
Crystal Structure of Lp1NTPDase with the
Subtype-Specific Inhibitor ARL 67156
Lp1NTPDase has been shown to be inhibited by the ATP analog,
ARL 67156 (6-N,N-diethyl-D-b-g-dibromomethylene adenosine
triphosphate) (Figure 4A), which exhibits subtype inhibition of
mammalian NTPDases (Sansom et al., 2007). To investigate
the structural basis of this inhibition, we determined the crystal
structure of the Lp1NTPDase-ARL 67156 complex to 2.0 A˚ reso-
lution and refined it to Rfactor and Rfree values of 18.4% and
22.4%, respectively (Table 1). The overall architecture of the
complex structure is very similar to the apo-structure with an
rmsd of 0.5 A˚ over 349 Ca atoms. One notable exception is the
conformation of R56, whose side chain shifts 6 A˚ to bind the
g-phosphate of ARL 67156. ARL 67156 is bound in an extended
conformation, similar to AMPPNP, with the adenine ring sand-
wiched between the helices K and H and the g-phosphate being
surrounded by the ACR regions (Figure 4B). The 6-N,N-diethyl
moiety sits within 4 A˚ of N302 and Y350 yet has no effect on
the conformation of the adenine base or the hydrophobic binding
pocket (Figure 4B). The adenine base stacks against Y346, while
the Y346 hydroxyl forms a hydrogen bond with the ribose moiety
O2 hydroxyl of the inhibitor, similar to what was observed in the
AMPPNP complex (Figure 4B). However, compared with the
Lp1NTPDase-AMPPNP structure, the g-phosphate of ARL
67156 made more direct contacts with Lp1NTPDase. Namely,
the oxygen atoms of the ARL 67156 g- phosphate are involved
in numerous direct hydrogen bonds with residues located in
the loop bridging the b strands 1 and 2 (S52, T53, R56) (Domain 1)
(Table S2; Figure 4B). Further, water-mediated hydrogen bonds
with the g-phosphate oxygen atoms involve the main chain
amide of A190, located in the loop that links the b-7 and b-8
strands, and residues T118 and A119 that follow the b-5 strand.
In addition, the a- and b-phosphate moieties form hydrogen
bonds to the main chain of G189 and water-mediated hydrogen
bonds with D186 and A190 (Figure 4B). The bromines have been
modeled with half occupancy. This is most likely due to radia-
tion-induced cleavage of the C-Br bond, a common phenomena
that has been noted previously (Ennifar et al., 2002). The dibro-
momethyl moiety is inverted relative to the b-phosphate group,
with the position of the bromines mirrored against the side chainrights reserved
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Figure 4. ARL 67156 Binding Site of Lp1NTPDase
(A) Structural formula of subtype NTPDase inhibitor ARL 67156 (Crack
et al., 1995).
(B) ARL 67156-mediated hydrogen bonds with Lp1NTPDase are
shown as black dashed lines. The water-mediated hydrogen bonds
are shown as magenta dashed lines with water molecules shown in
orange. The bromine ions are shown in magenta. Electron density
maps shown are Fo - Fc simulated annealing omit maps contoured
at 3s.
(C) Superposition of ARL 67156 (yellow) with the bromine ions are
shown in green; Lp1NTPDase structure (blue) onto AMPPNP
(magenta)-Lp1NTPDase structure.
Structure
Structure of Legionella NTPDaseof T53 at a distance of 3.7 A˚. Accordingly, the crystal structure
of the Lp1NTPDase-ARL 67156 complex provides insight into
how this inhibitor specifically interacts with an NTPDase family
member.
Comparison of AMPPNP and ARL 67156 Binding
to Lp1NTPDase
The structures of Lp1NTPDase-AMPPNP and Lp1NTPDase-
ARL 67156 are very similar (Figure 4C). Namely, the adenine
base of both AMPPNP and ARL 67156 is stacked in a similar
position against Y346 and both also hydrogen bond to the O2
hydroxyl from the ribose moiety (Figures 3A and 4B). However,
in comparison to ARL 67156 the a- and b-phosphates of
AMPPNP are located in different positions and make fewer direct
contacts with the protein; instead, most interactions are medi-
ated through water molecules. The b-phosphate of AMPPNP is
separated from the b-phosphate of ARL 67156 by over 4 A˚.
This also results in the g-phosphate of AMPPNP not extending
as far as the g-phosphate of ARL 67156, which consequently
enables the latter moiety to make more extensive hydrogen
bonding to the ACR1 region than AMPPNP (Figure 4B, compare
to Figures 3A and 4B). The additional hydrogen bonds in ARL
67156 binding suggest how the slight increase in binding affinity
for ARL 67156 is achieved.
Comparison of the Active Site of Lp1NTPDase
with RnNTPDase2
The active site of Lp1NTPDase displays sequence similarities to
the eukaryotic NTPDases and, together with the crystal structureStructure 18, 228–238, Fof NTPDase2 from R. norvegicus, permits comparative
analyses between these NTPDase subfamilies. In com-
parison to the Lp1NTPDase-AMPPNP structure, the
AMPPMP is shifted within the RnNTPDase2 binding cleft
(Figure 5A). In the Lp1NTPDase structure, the adenine
base of AMPPNP packs against Y346 (located on loop
between helix J and K) and the residue N302 on helix H.
These contacts are equivalent in the RnNTPDase2 struc-
ture to R394 (located on loop between helix J and K)
and Y350 on helix H, respectively. The difference in the
positions of the base-binding residues is concomitant
with a difference in the positioning of adenine base of
6 A˚ (Figure 5A).
In comparison to the Lp1NTPDase-AMPPNP structure,
this different positioning of the adenine base enables the
AMPPNP to further bridge the interdomain cleft in theRnNTPDase2 structure (Figure 5A). In the RnNTPDase2-
AMPPNP structure, the g-phosphate is positioned to be hydro-
lyzed by the nucleophilic attack of a water molecule. This water
molecule is located approximately 3 A˚ from the activating
carboxylate group of E165 (Figure 5A). Lp1NTPDase also has
a glutamate (E159) in the same position, which is conserved
throughout the NTPDase family (Figures 5A and 2A). However,
in Lp1NTPDase, this conserved E159 is over 7 A˚ from the
g-phosphate and no bridging water molecule is observed. This
suggests that the g-phosphate needs to be repositioned for
cleavage (Figure 5A).
The shifted conformation of AMPPNP in the RnNTPDase2
structure also resulted in different contacts with the ACR 1 and
ACR 4 regions when compared to Lp1NTPDase-AMPPNP. The
ACR 1 and 4 regions of Lp1NTPDase and RnNTPDase2 are
involved in the binding of the b- and g-phosphates of ATP.
However, in Lp1NTPDase, the ACR 1 region binds to the g-phos-
phate, while the ACR 4 region residues (D186 and G189) bind to
the a- and b-phosphates (Figure 5B). In the RnNTPDase2-
AMPPNP complex, the reverse occurs, whereby the ACR 1
region (S48, S49, and H50) binds to the b-phosphate and ACR
4 region to bind to the g-phosphate (Figure 5C).
All NTPDase family members require divalent metal ions
for enzyme activity, and Lp1NTPDase has been shown to
require either Mg2+, Ca2+, or Zn2+ (Sansom et al., 2008a).
In RnNTPDase2, three residues (D45, D201, and W436), in
conjunction with the b- and g-phosphate groups, form an octa-
hedral coordination geometry for the Ca2+ ion (Figure 5D). These
three residues involved in the metal ion binding are conserved inebruary 10, 2010 ª2010 Elsevier Ltd All rights reserved 233
Figure 5. Active Site Comparison of
Lp1NTPDase with RnNTPDase2
Superposition of the AMPPNP-Lp1NTPDase
structure (gray) and the RnNTPDase2 (light green)
using the C-alpha coordinates of all residues.
(A) The catalytic base E165 of RnNTPDase2 (light
green) is hydrogen bonded (dashed lines) to the
putative nucleophilic water that attacks g-phos-
phate of AMPPNP (blue). The nucleophilic water
also forms water-mediated hydrogen bonding
with Q208 of RnNTPDase2. The conserved cata-
lytic residues in Lp1NTPDase are shown in gray,
while AMPPNP is shown in magenta.
(B) Lp1NTPDase ACR1 residues (R56, T53, and
S52) mediate binding with the g-phosphate of
ARL 67156 (magenta), while ACR4 residues
(D186, G189, and A190) mediate the binding with
the b- and a-phosphates.
(C) RnNTPDase2 ACR 1 region (H50, S49, S48)
mediates the binding of the b-phosphate, while
ACR 4 (G204, A205, S206) binds to the g-phos-
phate.
(D) The calcium binding site of RnNTPDase2,
showing calcium ion (blue sphere) being coordi-
nated by water-mediated hydrogen bonds
(magenta dashed lines) via residues W346, D49,
D201, and the g- and b-phosphate of AMPPNP
(blue). The conserved residues of Lp1NTPDase
(gray) are superimposed onto the RnNTPDase2
structure with AMPPNP shown in magenta.
Structure
Structure of Legionella NTPDasethe Lp1NTPDase structure, indicating that the Ca2+ binding site
is conserved between Lp1NTPDase and NTPDase2 (Figure 5D).
Similar to what is observed in the RnNTPDase2 structure, it is
presumed that the coordination of the Ca2+ ion within the active
site of Lp1NTPDase is dependent upon binding to the g- and
b-phosphates of ATP. Presumably due to the flexibility of the
phosphate groups of AMPPNP in the active site of Lp1NTPDase,
the Ca2+ ion was indistinguishable from water molecules in the
electron density. In an attempt to identify the metal ion binding
site in Lp1NTPDase, several soaks were performed with more
electron dense calcium substitutes such as Cd2+ and Sr2+.
However, no clear electron density was observed for these
ions. To highlight that Ca2+ ions are present in the active site of
Lp1NTPDase in complex with AMPPNP, crystal soaks were
also performed in the absence of Ca2+. In these structures, the
phosphate groups of AMPPNP do not enter the active site
(data not shown). Further mutagenesis experiments were under-
taken to confirm the role of the putative metal ion coordinating
residues.
Critical Residues for Enzyme Activity of Lp1NTPDase
A recent study examined mutation of residues R122A, E159A,
N168A, Q189A, and W384A in the ACR regions of Lp1NTPDase
that are conserved across the NTPDase family (Figures 2A and
Figure 6A) (Sansom et al., 2008a); these mutations can now be
put in a structural context (Figure 6A). E159 is proposed to act
as the catalytic base for the hydrolysis of the phosphates, and
consistent with this, the E159A mutation resulted in complete
loss of activity (Sansom et al., 2008a). In addition, there is a strict
requirement for the positioning of the catalytic base (Drosopou-234 Structure 18, 228–238, February 10, 2010 ª2010 Elsevier Ltd Alllos et al., 2000; Yang et al., 2001), which is maintained by R126 in
the RnNTPDase2 structure, while Q208 positions the catalytic
water molecule for attack by E165 (Figure 5A). The residues
are structurally conserved (R122, Q189) in the Lp1NTPDase
and mutation of these residues to alanine resulted in a complete
loss of activity, thereby further strengthening the likelihood that
E159 is the catalytic base in Lp1NTPDase. The N168A mutation
was proposed to be directly involved in ATP binding, due to the
50% reduction in enzyme activity and a 3-fold weaker Km when
compared to the wild-type. However, N168 is located at the
opposite end of the helix from the location of E159 (Figure 5A);
thus, the effect of the N168A mutation appears to be indirect.
The W384A mutation resulted in a complete loss of enzyme
activity, and this could be attributed to the fact that this trypto-
phan is involved in the coordination of the Ca2+ ion (Figure 5D).
To further address the residues implicated in the catalysis, we
made a series of Lp1NTPDase mutants at positions 49, 56, and
346 and investigated their impact on the relative activity toward
ATP/ADP catalysis (Figure 6B) and on the survival of L. pneumo-
phila in macrophages (Figure 6C). D49 is involved in the Ca2+
binding, and consistent with this, the D49N mutation reduced
the enzyme activity by 50% (Figure 6B). Both Y346 and R56
bind ATP, whereby Y346 pi-stacks against the adenine base
and R56 from the ACR1 region binds to the phosphate moiety
(Figure 6A). The ACR 1 region of Lp1NTPDase is not completely
conserved within the mammalian NTPDase family members,
with a notable difference being an arginine or histidine at position
56 (Figure 2A). The Y346A mutation causes an approximately
60% loss in ATP and ADP hydrolysis, while the Y346F mutation
maintains full activity, revealing that pi-stacking with Y346 is ofrights reserved
Figure 6. Relative Enzyme Activity of Lp1NTPDase Mutants
(A) Residues in Lp1NTPDase that were mutated for analysis of catalytic
activity. AMPPNP is shown in magenta.
(B) Relative activity of Lp1NTPDase and various mutants for ATP and ADP. The
results are expressed as percentage of the relative activity of wild-type (WT)
and are the mean ± SD of three experiments.
(C) Effect on bacterial replication in THP-1 macrophages. Results are
expressed as the log10cfu of viable bacteria present in the extracellular
medium and associated cells at specific time points after inoculation, mean
± SD of least three independent experiments from duplicate wells.
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Structure of Legionella NTPDasecritical importance (Figure 6B). The R56A mutation results in
a complete loss of ATP and ADP hydrolysis by Lp1NTPDase,
supporting the importance of this residue in enzymatic function
(Figure 5B). The R56K mutation converts Lp1NTPDase to an
ATPase, as it still maintains 50% ATPase activity; however, it
results in a complete loss of ADPase activity. Interestingly, the
difference in ATPase activity between R56K and Y346A also
results in a difference in macrophage survival, with the L. pneu-
mophila Y346A mutant not surviving as well as R56K or wild-type
(Figure 6C). It appears that while the catalytic mechanism is
conserved between NTPDase1 and NTPDase2 family members,Structure 18, 228subtle differences in the active sites underlie the different ATP/
ADP ratios between the families. In addition we demonstrate
that the level of ATPase rather than ADPase activity is critical
for survival of Legionella within macrophages.
DISCUSSION
Recent studies have suggested that several intracellular patho-
gens can manipulate host ATP levels to aid their survival by inter-
fering with purinergic signaling (Kolli et al., 2008; Yilmaz et al.,
2008; Zaborina et al., 1999). Whether the pathogens directly
manipulate extracellular levels of ATP or act on the intracellular
reservoirs of ATP that are potential sources of extracellular
ATP is unknown. However, many intracellular eukaryotic patho-
gens contain NTPDase mimics of the mammalian NTPDases that
control purinergic signaling. Their role in microbial physiology
and their contribution to the pathogenesis of disease is poorly
understood (Roberto Meyer-Fernandes, 2002; Sansom et al.,
2008b). To understand the structural basis of NTPDase function
from pathogenic organisms, we have determined the crystal
structure of Lp1NTPDase, a prokaryotic NTPDase. The structure
confirmed that the Legionella NTPDase adopted a similar fold
to mammalian NTPDases. Furthermore, structural comparison
and mutagenesis experiments indicated that the catalytic base
and Ca2+ coordinating residues are structurally conserved.
This suggests that the mechanism of hydrolysis is conserved
between Legionella and mammalian NTPDases.
The structure of the Lp1NTPDase-AMPPNP complex revealed
that the majority of contacts with the phosphate tail were water
mediated, suggesting that the active site of Lp1NTPDase
allows for inherent movement of the phosphate tail of AMPPNP.
It was shown that residues in ACR 1 and ACR 4 of Lp1NTPDase
bind predominantly to g- and b-phosphates, respectively.
However, in the RnNTPDase2 structure, the opposite occurs:
ACR 1 and ACR 4 regions interact with the b- and g- phosphate,
respectively. This results in the g-phosphate of AMPPNP in
the RnNTPDase2 structure being more extended than in the
Lp1NTPDase structure. Consequently, the g-phosphate of
AMPPNP in the RnNTPDase2 structure is in a position to be
cleaved via nucleophilic attack by a water molecule that is acti-
vated by a glutamate residue (Zebisch and Stra¨ter, 2008).
However, the g-phosphate of AMPPNP in Lp1NTPDase is posi-
tioned such that E159 cannot hydrolyze the phosphate and thus
would require the g-phosphate to move toward E159 for hydro-
lysis to occur. This movement could occur in either one of two
ways: the domains move closer together or the phosphate back-
bone can move to position the g-phosphate closer to E159. The
former has been observed in several members of the ASKHA
superfamily (Aleshin et al., 2000; Kristensen et al., 2004, 2008;
Schuler, 2001). In particular, the exopolyphospatase structure
has been solved in the absence and in the presence of a ligand,
and a 11.5 difference between the ‘‘open’’ and ‘‘closed’’ confor-
mation was observed. The ‘‘open’’ conformation represents the
active state, as the ligand cannot bind to the ‘‘closed’’ conforma-
tion due to steric clashes (Kristensen et al., 2004, 2008). This
movement has also been referred to as the ‘‘butterfly motion,’’
due to different conformations observed in several actin struc-
tures (Schuler, 2001). There was no large domain movement
observed in the RnNTPDase2 structure complexed with AMP–238, February 10, 2010 ª2010 Elsevier Ltd All rights reserved 235
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Structure of Legionella NTPDaseor AMPPNP, suggesting that domain movement may not be
involved in activity of NTPDases. As the phosphate backbone
of AMPPNP resides within a water-filled cavity in Lp1NTPDase,
we propose that movement of the phosphate backbone would
allow the b-phosphate to be positioned for subsequent
cleavage. In addition, qualitative in situ enzyme activity assay
(see Experimental Procedures) suggested that Lp1NTPDase
has enzyme activity in the crystalline state. This suggests that
large-scale conformational movement of Lp1NTPDase to posi-
tion the g-phosphate would be unlikely. We suggest that the
active site of Lp1NTPDase allows for the movement of the intrin-
sically flexible phosphate backbone of ATP, which may account
for the differential rates of ATP/ADP hydrolysis between the
Lp1NTPDase and RnNTPDase2 family members (Grinthal and
Guidotti, 2002; Sansom et al., 2008a).
The ratio of ATP:ADP hydrolysis is dependent on the quater-
nary structure of the NTPDase family (Chen and Guidotti, 2001;
Grinthal and Guidotti, 2000, 2002). Membrane-bound NTPDase1
have been shown not to release ADP. However, soluble
recombinant NTPDase1 releases ADP and then rebinds ADP to
further hydrolyze it to AMP. Soluble apyrases or NTPDases
that contain a single transmembrane domain differ within the
ACR1 region (Chen and Guidotti, 2001). The major difference is
the presence of a histidine in NTPDases with two transmem-
brane domains, except NTPDase3, 4, and 7, whereas other
NTPDases possess an arginine (Chen and Guidotti, 2001). The
ACR1 domain of RnNTPDase2 interacts with the b-phosphate
via His50, while the ACR1 region in Lp1NTPDase interacts with
g-phosphate of ATP via R56, suggesting that Lp1NTPDase
may release ADP during its reaction cycle. Mutation of the
corresponding histidine in the membrane-bound form of rat
NTPDase1 to glycine or serine results in conversion of the
NTPDase to an ADPase as the hydrolysis of ATP is abolished
and 50% ADPase activity is retained. However, the mutation
of histidine makes no difference to the activity of soluble
NTPDase1, suggesting quaternary structure plays an important
role in catalytic mechanism (Grinthal and Guidotti, 2000). When
the corresponding R56 in Lp1NTPDase was mutated to alanine,
there was a complete loss of ATP and ADP hydrolysis, suggest-
ing that R56 is crucial to catalysis. However the R56K mutation
converts Lp1NTPDase into an ATPase, due to a partial reduction
in ATP hydrolysis, yet complete abolishment of ADP hydrolysis.
These observations further support the notion that different cata-
lytic mechanisms underlie mammalian NTPDase1 activity and
the activity of other NTPDase1 family members.
The functional differences between mammalian NTPDase
enzymes and microbial NTPDase members could be exploited
for the development of novel therapeutics. The structure of
Lp1NTPDase with the subtype-specific inhibitor ARL 67156
revealed that it binds to Lp1NTPDase in a manner similar to
ATP. ARL 67156 is a poor inhibitor of Lp1NTPDase, with a Ki
of approximately 0.5 mM (data not shown). Lp1NTPDase binds
ATP with a similar affinity despite ARL 67156 differing from
ATP by two modifications: (1) the phosphodiester bond between
the b- and g-phosphates is substituted by a phosphodibromo-
methyl bond, and (2) two ethyl groups are added to the primary
amine (Crack et al., 1995; Sansom et al., 2008a). ARL 67156
binds to mammalian NTPDase1 with a higher affinity than
Lp1NTPDase (11 mM compared to 0.5 mM), which directly corre-236 Structure 18, 228–238, February 10, 2010 ª2010 Elsevier Ltd Alllates with their higher binding affinity for ATP (Grinthal and Gui-
dotti, 2000; Wang et al., 1998), and suggests that ATP makes
additional contacts with NTPDase1 family members (Le´vesque
et al., 2007). Sequence analysis reveals that mammalian
NTPDase1 has a phenylalanine substituted in place of the
Lp1NTPDase N302 residue. This phenylalanine residue may
form an extra pi-stacking interaction with the adenine ring that
may increase the binding affinity. Similarly, subtle differences
in the phosphate binding regions between mammalian
NTPDase1 and Lp1NTPDase may directly impact on ATP
binding affinity. Recent data has shown that ARL 67156 can
inhibit mammalian NTPDase1 and NTPDase3 but not NTPDase2
(Le´vesque et al., 2007). We suggest that this is attributable to the
differing binding modes of the adenine base of ATP between
NTPDase1 and NTPDase2. Furthermore, the inherent flexibility
implied by the Lp1NTPDase-AMPPNP structure may aid in
accommodating the bulkier ARL 67156 inhibitor in the NTPDase
active site compared to NTPDase2.
Previous studies with the catalytically inactive mutant (E159A)
showed that the survival and replication of L. pneumophila in
macrophages is dependent upon the enzyme activity of
Lp1NTPDase (Sansom et al., 2007, 2008a). Further, structure-
based mutagenesis experiments showed that the survival and
replication of L. pneumophila in macrophages is specifically
dependent upon the ATPase activity of the enzyme. The
Y346A mutation reduced ATPase activity by approximately
80%, whereas the R56K mutation reduced ATPase activity by
60%. When transformed into Lp1NTPDase null L. pneumophila,
the Lp1NTPDase Y346A mutant did not survive as well as
wild-type Lp1NTPDase and the Lp1NTPDase R56K mutant in
macrophages. Thus, the acquisition and mimicry of eukaryotic
NTPDase activity is an important step in the evolution of the
pathogen and its adaptation to an intracellular niche. It is likely
that other microbial NTPDases contribute to host-pathogen
interactions and play an important role in the biology of diverse
infectious diseases.EXPERIMENTAL PROCEDURES
Expression, Purification, and Crystallization
The recombinant construct of Lp1NTPDase comprised residues 41 to 393
cloned with an N-terminal (His)6-tag into the pRSET expression vector as
detailed in Sansom et al. (2007). The resultant N-terminal amino acid sequence
of recombinant Lp1NTPDase is MRGSHHHHHHGMASMTGGNNMGRD
LYDDDDKDPKHSC, where the underlined sequence is the Lp1NTPDase
protein starting at residue 41. The recombinant Lp1NTPDase was overex-
pressed in the cytosol of E.coli BL21 (DE3) using auto-induction medium as
described Studier (2005) at 25C for 24 hr and cells were harvested by centri-
fugation at 6000 g for 20 min. The cells were resuspended in buffer A (25 mM
Tris-HCl pH 8.0, 300 mM NaCl, 5mM imidazole, 2mM EDTA) and lysed by
French press, and the resulting cell lysate centrifuged at 30000 g for 30 min.
The soluble fraction was applied to 5ml Ni-sepharose HiTrap (GE Healthcare)
equilibrated in buffer B (buffer A + 30mM imidazole). Lp1NTPDase was eluted
using buffer C (buffer A + 1M imidazole). Lp1NTPDase was applied to a 16/60
Superdex 200 prep-grade (GE Healthcare) column in 20 mM Tris-HCl pH 8.0,
150 mM NaCl, 2 mM EDTA. The fractions containing Lp1NTPDase were
pooled and then diluted 1:3 in 20 mM Tris-HCl pH 8.0 and applied to
a Mono Q 5/50 GL (GE Healthcare) column in 20 mM Tris-HCl pH 8.0,
50 mM NaCl and 2 mM EDTA. Lp1NTPDase was eluted using a linear
gradient of 0-1 M NaCl in 20 mM Tris-HCl pH 8.0 and 2 mM EDTA. The
purified protein was concentrated to 7 mg/ml in buffer D (25 mM Tris-HCl
pH 8.0 + 100 mM NaCl).rights reserved
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Structure of Legionella NTPDaseCrystallization and X-Ray Data Collection
Crystals of apo-Lp1NTPDase and the Lp1NTPDase-ARL 67156 complex were
produced by the hanging-drop vapor-diffusion method. 1 ml of protein solution
was mixed with 1 ml of precipitant solution (20%–24% (w/v) PEG 3350, 0.2 M
Na Formate, 0.1 M Bis-Tris propane pH 6.5) and incubated at 294 K. For co-
crystallization with ARL 67156, 20 mM ARL 67156 (Sigma) and 5 mM Calcium
was added to the precipitant solution. Two distinct crystal forms were
produced from these conditions. Crystal form I typically appeared after four
days of incubation as hexagonal bipyramids that grew to dimensions 0.4 3
0.3 3 0.3 mm. Form I crystals diffracted to 2 A˚ resolution and appeared to
be in the trigonal point group with unit cell dimensions a = b = 129.2 A˚,
c = 160.9 A˚ and were found to be twinned with a twinning fraction of 0.5. Struc-
ture solution with these crystals proved problematic and so was not pursued
further. Crystal form II typically appeared after two months of incubation as
hexagonal plates that grew to dimensions 0.23 0.23 0.1 mm. Form II crystals
were used for the subsequent structure determination. Data were collected
from crystals soaked in mother liquor with 20% glycerol added prior to
flash-cooling in a liquid nitrogen stream at 100 K. Apo-Lp1NTPDase data
were collected at beamline 23ID-B GM/CA at the Advanced Photon Source,
Argonne National Laboratories. Data was collected in 0.5 oscillations from
a crystal mounted 120 mm from a Quantum-210 CCD detector. Lpg1905-
ARL 67156 data were collected on the PX1 beamline at the Australian Synchro-
tron. Data was collected in 0.5 oscillations from a crystal mounted 200 mm
from a Quantum-210 CCD detector. The form II crystals belong to spacegroup
P321 with unit cell dimensions a = b = 103.8 A˚, c = 75.4 A˚. The data collection
statistics are summarized in Table 1. Lp1NTPDase-AMPPNP crystals were
obtained by soaking Lp1NTPDase crystals with 10mM CaCl2 and 10mM
AMPPNP. Data were collected as detailed above for the Lp1NTPDase-ARL
67156 crystals (Table 1).
Structure Determination and Refinement
Structure determination and refinement are described in the Supplemental
Information. Methods used to determine domain orientations are also given
in Supplemental Information.
Crystallographic, Enzymatic Assays, and Mutation Studies
The enzyme assays used to determine activity both in solution and crystalline
state are described in the Supplemental Information. Methods used to
generate mutants of Lp1NTPDase1 and intracellular growth in macrophages
are also given in Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.str.2009.11.014.
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